Knockout of latrophilin-3 in Sprague-Dawley rats causes hyperactivity, hyper-reactivity, under-response to amphetamine, and disrupted dopamine markers

NEUROBIOLOGY OF DISEASE

卷:130

Article

Regan, Samantha L.¹  Hufgard, Jillian R.²  Pitzer, Emily M.¹  Sugimoto, Chiho³  Hu, Yueh-Chiang⁴  Williams, Michael T.³  Vorhees, Charles V.³ 

[1] Univ Cincinnati, Neurosci Grad Program, Cincinnati, OH 45221 USA

[2] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA

[3] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Neurol,Dept Pediat, Cincinnati, OH 45221 USA

[4] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Div Dev Biol,Dept Pediat, Cincinnati, OH 45229 USA

关键词: Latrophilin-3 (LPHN3 or ADGRL(3));    ADHD;    Dopamine D1 receptor (DRD1);    Tyrosine hydroxylase;    Aromatic amino acid decarboxylase (AADC);    DARPP-32;    Dopamine transporter (DAT);   

DOI  :  10.1016/j.nbd.2019.104494

来源: Elsevier

【 摘 要 】

Attention deficit hyperactivity disorder is a pervasive developmental disorder characterized by inattention, impulsivity, and hyperactivity and is 75-90% heritable. Latrophilin-3 (LPHN3; or ADGRL(3)) is associated with a subtype of ADHD, but how it translates to symptoms is unknown. LPHN3 is a synaptic adhesion G protein coupled receptor that binds to fibronectin leucine rich transmembrane protein 3 and teneurin-3 (FLRT3 and TEN-3). We created a null mutation of Lphn3 (KO) in Sprague-Dawley rats using CRISPR/Cas9 to delete exon-3. The KO rats had no effects on reproduction or survival but reduced growth. KO females showed catch-up weight gain whereas KO males did not. We tested WT and KO littermates for home-cage activity, anxiety-like behavior, acoustic startle response, and activity after amphetamine challenge. Expression of Lphn3-related genes, mono-amines, and receptors were determined. Lphn3 KO rats showed persistent hyperactivity, increased acoustic startle, reduced activity in response to amphetamine relative to baseline, and female-specific reduced anxiety like behavior. Expression of Lphn1, Lphn2, and Flrt3 by qPCR and their protein products by western-blot analysis showed no compensatory upregulation. Striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase (AADC), and the dopamine transporter were increased and dopamine D1 receptor (DRD1) and dopamine- and cAMP-regulated neuronal phosphoprotein (DARPP-32) decreased with no changes in DRD2, DRD4, vesicular monoamine transporter-2, N-methyl-D-aspartate (NMDA)-NR1, -NR2A, or -NR2B. LPHN3 is expressed in many brain regions but its function is largely unknown. Data from human, mouse, zebrafish, Drosophila and our new Lphn3 KO rat data collectively show that its disruption is significantly correlated with hyperactivity and associated striatal changes in dopamine markers.

【 授权许可】

Free